NeuroCritical Care Fellowship Program

Neurocritical care is an exciting specialty, and the demand for specialists in our field is growing rapidly. Our fellowship program reflects our group’s enthusiasm for our specialty. Neurocritical care bridges the fields of neurology, neurosurgery, neuroradiology, trauma, neuroanesthesiology, and critical care medicine, and our fellowship provides wide exposure to these disciplines. One unique aspect of our program is the strong collegiality across all of these specialties within our medical center, and each of our neurocritical care faculty are within the Departments of Neurology and Neurosurgery. Furthermore, our program has and continues to expand with the addition of neurotrauma in May 2018 with the opening of the level 1 trauma center, and with the addition of our neurology Chairman, Shyam Prabhakaran, MD and the formation of a dedicated of Stroke Service.

In addition to the outstanding clinical experience our fellowship provides, each fellow will participate in research and quality improvement activities (see Research below). Special efforts will be made to guide the fellow in designing and organizing his/her own projects that can be realistically accomplished during their fellowship. Scholarly productivity through publications and presentations will be encouraged and fostered. At the completion of the fellowship experience, University of Chicago Medical Center trained Neurocritical Care fellows are uniquely skilled clinically, have a track record of scholarly accomplishments, and are ready to either build their own program or valuably contribute to an established program.

Our Fellowship is accredited by the United Council for Neurology Subspecialties.

First Comprehensive Stroke Center in Chicago, opened as a Level 1 Trauma Center in May 2018

Emergency Neurological Life Support and Acute Trauma Life Support certifications are encouraged and funded by the Department

  • Abundant opportunities and sufficient time for research, quality improvement, and educational projects, including simulation
  • BOOST III Trial: phase III RCT to evaluate outcome with PbtO2 directed therapy vs. ICP directed therapy in severe TBI
  • MISTIE III: Minimally Invasive Surgery Plus rt-PA for intracerebral Hemorrhage Evacuation is a phase III RCT evaluating outcome in patients with ICH treated with catheter directed lytic therapy
  • CLEAR III: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
  • Penetrating traumatic brain injury
  • Prognosis after cardiac arrest
  • Stroke code activation demographics
  • Neurologic complications of ventricular assist devices

Cutting edge equipment, including continuous and quantitative EEG monitoring, point-of-care ultrasound, Licox, and non-invasive hemodynamic monitoring systems

Learn more about or Program Leadership.

  • Attendance at national conferences encouraged and supported
  • Each Fellow receives an "Education Fund" in the amount of $1,000 per year
  • Additional funding is available for Fellows who present at a national conference